Your browser doesn't support javascript.
loading
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response.
Mei, Yan; Wang, Xiumei; Zhang, Ji; Liu, Dan; He, Junjie; Huang, Chunliu; Liao, Jing; Wang, Yingzhao; Feng, Yongyi; Li, Hongyu; Liu, Xiuying; Chen, Lingdan; Yi, Wei; Chen, Xi; Bai, Hong-Min; Wang, Xinyu; Li, Yiyi; Wang, Lixiang; Liang, Zhigang; Ren, Xianwen; Qiu, Li; Hui, Yuan; Zhang, Qingling; Leng, Qibin; Chen, Jun; Jia, Guangshuai.
Afiliación
  • Mei Y; GMU-GIBH Joint School of Life Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou, China.
  • Wang X; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Zhang J; Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Liu D; Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • He J; Department of Neurosurgery, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Huang C; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Liao J; Center of Clinical Oncology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China.
  • Wang Y; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Feng Y; GMU-GIBH Joint School of Life Sciences, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Guangzhou, China.
  • Li H; Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Liu X; Jiangsu Center for the Collaboration and Innovation of Cancer Biotherapy, Cancer Institute, Xuzhou Medical University, Xuzhou, China.
  • Chen L; Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Yi W; Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Chen X; GMU-GIBH Joint School of Life Sciences, Guangzhou Medical University, Guangzhou, China.
  • Bai HM; Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Wang X; Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Li Y; Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Wang L; Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Liang Z; Changping Laboratory, Beijing, China.
  • Ren X; The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Qiu L; State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
  • Hui Y; Department of Biology, Southern University of Science and Technology, Shenzhen, China.
  • Zhang Q; Department of Neurosurgery, General Hospital of Southern Theater Command, Guangzhou, China.
  • Leng Q; Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Chen J; Guangdong Engineering & Technology Research Center for Disease-Model Animals, Laboratory Animal Center, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
  • Jia G; Department of Immunology and Microbiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
Nat Cancer ; 4(9): 1273-1291, 2023 09.
Article en En | MEDLINE | ID: mdl-37460871
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Glioblastoma Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido